Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
We come to your home, office, or hotel room, 24/7
Check out special pricing options for sectional purchase and startup companies Grand View Research has segmented the global GLP-1 receptor agonist market based on product: GLP-1 Receptor Agonist Product Outlook (Revenue, USD Million, 2016 2027) Victoza Ozempic Trulicity Bydureon Saxenda Others About Grand View Research Grand View Research, Inc
Semaglutide works by mimicking the action of an incretin hormone, GLP-1 (glucagon-like peptide-1), which is involved in regulating blood sugar levels
Data from the IFEBP revealed that only 22% of employers coverprescription weight loss drugs, although the percentage is higher for employers with 5,000 or more employees
Expected timeline: Analyst commentary points to a potential NDA filing by Lilly in Q4 2026 at the earliest, with U.S
US$ 23.84
US$ 28.46
US$ 28.06
US$ 21.47
US$ 21.77
US$ 22.27
US$ 24.70
US$ 27.81
US$ 27.87
US$ 20.17
US$ 28.01
